Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Use of intrapleural bortezomib in myelomatous pleural effusion.

Authors:
Emilio Iannitto Viviana Minardi Claudio Tripodo

Br J Haematol 2007 Nov;139(4):621-2

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2007.06735.xDOI Listing
November 2007

Publication Analysis

Top Keywords

pleural effusion
4
myelomatous pleural
4
bortezomib myelomatous
4
intrapleural bortezomib
4
effusion
1
myelomatous
1
pleural
1
intrapleural
1

Similar Publications

The role of nitric oxide in pleural disease.

Authors:
Ourania S Kotsiou Konstantinos I Gourgoulianis Sotirios G Zarogiannis

Respir Med 2021 Feb 23;179:106350. Epub 2021 Feb 23.

Department of Physiology, Faculty of Medicine, University of Thessaly, BIOPOLIS, 41500, Larissa, Greece.

Nitric oxide (NO) regulates various physiological and pathophysiological functions in the lungs. However, there is much less information about the effects of NO in the pleura. The present review aimed to explore the available evidence regarding the role of NO in pleural disease. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.

Authors:
Bjørn Henning Grønberg Kristin Toftaker Killingberg Øystein Fløtten Odd Terje Brustugun Kjersti Hornslien Tesfaye Madebo Seppo Wang Langer Tine Schytte Jan Nyman Signe Risum Georgios Tsakonas Jens Engleson Tarje Onsøien Halvorsen

Lancet Oncol 2021 Mar;22(3):321-331

Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Background: Concurrent chemoradiotherapy is standard treatment for limited stage small-cell lung cancer (SCLC). Twice-daily thoracic radiotherapy of 45 Gy in 30 fractions is considered to be the most effective schedule. The aim of this study was to investigate whether high-dose, twice-daily thoracic radiotherapy of 60 Gy in 40 fractions improves survival. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

NUT Midline Carcinoma of the Lung: Computed Tomography Findings in 10 Patients.

Authors:
Amy Inji Chang Tae Sung Kim Joungho Han Tae Jung Kim Joon Young Choi

J Comput Assist Tomogr 2021 Mar 2. Epub 2021 Mar 2.

From the Departments of Radiology and Center for Imaging Science Pathology Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Objective: The aim of the study was to evaluate computed tomography (CT) findings of pulmonary NUT midline carcinoma.

Methods: We assessed clinical and CT features of pulmonary NUT carcinoma in 10 consecutive patients (M:F, 7:3; mean, 39 years).

Results: The primary tumors (size range, 15-65 mm) manifested as either a peripheral tumor (5/10) or a central tumor (5/10). Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Malignant pleural mesothelioma in a kidney transplant recipient.

Authors:
Wasinee Traipipitsiriwat Chayanon Songsomboon Detajin Junhasavasdikul Viboon Boonsarngsuk Wipawi Klaisuban

Thorac Cancer 2021 Mar 4. Epub 2021 Mar 4.

Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Post-transplantation malignancy is one of the most common complication-related mortality in transplant recipients. Here, we report the case of a kidney transplant patient for 2 years with malignant pleural effusion that was subsequently diagnosed as malignant pleural mesothelioma. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Management of Spontaneous Chylothorax in a Neonate: A Medical Challenge.

Authors:
Irfan Ullah Shahzad Rauf Jahanzeb Malik Kiran Shafiq Khan Abdul Wali Khan

Cureus 2021 Jan 27;13(1):e12942. Epub 2021 Jan 27.

Internal Medicine, College of Physician and Surgeons Pakistan, Peshawar, PAK.

Chylothorax or collection of lymphatic fluid in the pleural space is an exceedingly rare cause of pleural effusion and respiratory distress in neonates. In adults, prompt diagnosis and effective treatment regimen can aid in the resolution of chylothorax; however, in neonates treating the condition can be an onerous challenge for the pediatricians due to the rarity and perplexing clinical presentation. We elucidate a case of spontaneous chylothorax in a 15-day-old neonate who presented to us with respiratory distress, chest indrawing, and cyanosis for nine days. Read More

View Article and Full-Text PDF
January 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap